L'épigénétique : enjeux scientifiques, éthiques et sociétaux, L'Act. Chim, vol.407, p.6, 2016. ,
Epigenetic protein families: a new frontier for drug discovery, Nat. Rev. Drug Discov, vol.11, p.384, 2012. ,
Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma, Expert Opin. Investig. Drugs, vol.16, p.1111, 2007. ,
Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors, Expert Rev. Anticancer Ther, vol.10, p.997, 2010. ,
Belinostat: first global approval, Drugs, vol.74, p.1543, 2014. ,
FDA approves new agent for multiple myeloma, J. Natl. Cancer Inst, p.165, 2015. ,
China's first homegrown pharma, Seeking Alpha ?, 2015. ,
Delivery of epidrugs, Drug Discov. Today, vol.19, p.1337, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01201998
Vorinostat with sustained exposure and high solubility in poly(ethylene glycol)-b-poly(DL-lactic acid) micelle nanocarriers: characterization and effects on pharmacokinetics in rat serum and urine, J. Pharm. Sci, vol.101, p.3787, 2012. ,
Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity, Adv. Drug Deliv. Rev, vol.91, p.3, 2015. ,
, Nanovecteurs ou particules et leur utilisation comme médicament et/ou agent de diagnostic, FR20110055761, WO2012FR51498, US2014219925 A1
Design of pH responsive clickable prodrugs applied to histone deacetylases inhibitors: a new strategy for anticancer therapy, Eur. J. Pharm. Biopharm, vol.85, p.862, 2013. ,
An easy and effective method to produce functionalized particles for cellular uptake, J. Polym. Sci. Part A: Polym. Chem, vol.51, p.176, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00918361
Nanoparticles produced by ring-opening metathesis polymerization using norbornenyl-poly(ethylene oxide) as a ligand-free generic platform for highly selective in vivo tumor targeting, Biomacromolecules, vol.14, p.2396, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-00931576
Histone deacetylase inhibitor-polymer conjugate nanoparticles for acid-responsive drug delivery, Eur. J. Med. Chem, vol.95, p.369, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01368838
Vorinostat-polymer conjugate nanoparticles for acid-responsive delivery and passive tumor targeting, Biomacromolecules, vol.15, p.4534, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01369441
Synthesis and modeling of new benzofuranone histone deacetylase inhibitors that stimulate tumor suppressor gene expression, J. Med. Chem, vol.52, p.3112, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00438795
Pharmacological characterization of histone deacetylase inhibitor and tumor cell-growth inhibition properties of new benzofuranone compounds, Current Cancer Drug Targets, vol.11, p.919, 2011. ,
New histone deacetylases inhibitors improve cisplatin antitumor properties against thoracic cancer cells, Oncotarget, vol.5, p.4504, 2014. ,
Histone deacetylase inhibitors delivery using nanoparticles with intrinsic passive tumor targeting properties for tumor therapy, vol.6, p.795, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01299450
, Activité antitumorale des NP 23. Quatre groupes (G1-G4) de souris C57Bl6 portant des tumeurs AK7 orthotopiques ont été traitées par injection intrapéritonéale de décitabine (4 ?g/g) aux jours 7 et 9, suivie d'injection intraveineuse de NP 21, vol.9
, Représentation du poids des tumeurs à la fin du traitement. B-D) Coupes histologiques après coloration HES représentatives de pancréas du groupe contrôle G1 (B)
, Les flèches indiquent les zones d'invasion du pancréas par les cellules tumorales. ns : non significatif
) valerie.heroguez@enscbp.fr (2) christophe.blanquart@inserm.fr (3) philippe.bertrand@univ-poitiers, p.1 ,